Filing Flows › Viemed Healthcare (VMD) › Capital expenditures
Viemed Healthcare (VMD) capital expenditures by quarter
Viemed Healthcare's capital expenditures were $7.5M in Q3 2026 (third quarter 2026), +2% from Q2 2026. Over the last 7 quarters it ranged from $5.5M (Q1 2026) to $15.5M (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $7.5M | +2% | +25% |
| Q2 2026 | $7.3M | +33% | -10% |
| Q1 2026 | $5.5M | -37% | -65% |
| Q4 2025 | $8.7M | +46% | — |
| Q3 2025 | $6.0M | -27% | — |
| Q2 2025 | $8.1M | -47% | — |
| Q1 2025 | $15.5M | — | — |
Q3 2026 at a glance
Viemed Healthcare, Q3 2026: revenue $80.7M (+12% year over year), operating margin 8.6%, net earnings $4.6M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Viemed Healthcare's capital expenditures?
Viemed Healthcare's capital expenditures were $7.5M in Q3 2026 (third quarter 2026), +2% from Q2 2026.
How has Viemed Healthcare's capital expenditures changed?
Over the last 7 quarters it ranged from $5.5M (Q1 2026) to $15.5M (Q1 2025).